Investment analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research note issued to investors on Thursday. The firm set a “buy” rating on the stock.
Mannatech Price Performance
Shares of MTEX stock opened at $8.47 on Thursday. The company has a market cap of $15.97 million, a P/E ratio of -9.52 and a beta of 1.17. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.17 and a quick ratio of 0.62. The stock’s 50-day moving average is $7.54 and its 200 day moving average is $7.61. Mannatech has a 1-year low of $6.75 and a 1-year high of $10.51.
Mannatech (NASDAQ:MTEX – Get Free Report) last issued its quarterly earnings data on Tuesday, August 13th. The company reported ($0.33) earnings per share (EPS) for the quarter. The firm had revenue of $27.74 million during the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%.
Insider Activity at Mannatech
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
See Also
- Five stocks we like better than Mannatech
- What is the FTSE 100 index?
- Survey Reveals: America’s Most Coveted Businesses in 2024
- What Are Dividend Contenders? Investing in Dividend Contenders
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.